Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
National Institutes of Health
Description
The SHINE program provides funding for innovative and high-quality research in nonmalignant hematology. It supports investigator-initiated R01 grant applications relevant to the missions of NIDDK, NIA, and NHLBI. The program focuses on advancing basic and early translational research in nonmalignant hematology, with priority topics that are updated yearly.
The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), a…
Source
Grant ID
PAS-25-205
Agency
National Institutes of Health
Subcategory/Subagency
National Institute of Diabetes and Digestive and Kidney Diseases
Key Dates
Opportunity Released
November 6, 2024
Open for Submission
November 6, 2024
Submission Deadline
January 6, 2028
Application Window Closes
January 6, 2028
Similar opportunities
- NIH Research Education Program (R25)
National Institutes of Health
- NIAID New Innovator Award
National Institutes of Health
- Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
National Institutes of Health
- NIH Research Education Program (R25)
National Institutes of Health
- Notice of Funding Opportunity (NOFO) for Time-Sensitive Ancillary Studies Related to the NIAMS Mission
National Institutes of Health